Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|4|6|513-519

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.4, Iss.6, 2008-11, pp. : 513-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nevirapine hastens liver fibrosis in HIV/HCV coinfection

By  

Reactions Weekly, Vol. 1, Iss. 1007, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Lopinavir/Ritonavir Pharmacokinetics in HIV and Hepatitis C Virus Co-Infected Patients without Liver Function Impairment: Influence of Liver Fibrosis

By Moltó José   Valle Marta   Blanco Asunción  

Clinical Pharmacokinetics, Vol. 46, Iss. 1, 2007-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

PI-based HAART slows fibrosis progression in HIV/HCV

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 890-904

Bentham Science Publishers

Access to resources Recommend Favorite

Liver transplantation for HIV/HCV coinfection: where is the controversy?

By Dannhorn Emily   O'Beirne James P  

Future Virology, Vol. 8, Iss. 7, 2013-07 ,pp. : 639-648

Future Medicine

Access to resources Recommend Favorite